ArrayScreen will exploit 'microarray' or '2DNA Chip' technology and the information provided by the Human Genome Project to develop revolutionary diagnostic tests to predict a variety of medical conditions such as cardiovascular disease.

To provide a software solution for in silico drug discovery and prediction of drug side effects. Ccnet exploit the explosion of post-genomic data produced by high-throughput technologies such as DNA microarrays and portein chips.

To provide effective cognitive test, measures and treatments for psychological challenges.

GEO has developed a novel, in-situ testing technique applicable to several niche construction quality control (CQC testing market, estimated at over 35m pa) within the rapidly growing environmental industry.

M-Rputer offer a range of value-added products/services to telecom carriers, such as traffic information and navigation SMS text messages, and a mobile callback service.

Schmode's first product, the Light Tile, will make the surfaces of a room glow. As the technology develops, surfaces will change colour. Schmode will offer the first off-the-shelf electroluminescent product for designers or commercial and personal spaces.

Collection and log-term storage of umbilical cord blood stem cells for the benefit of the newborn child and their family. Additional business activities will include viral screening and tissue-typing (genetic identification) of the colleced stem cells.

To transform logistics through location technology.